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Background: Salivary gland cancer (SGC) is one of the common malignancies of the head and neck area. It
develops in the minor and major salivary glands and sometimes metastasizes to other organs, particularly to the
lungs. Inhibitors of differentiation (Id) proteins are negative regulators of basic helix-loop-helix transcription factors
that control malignant cell behavior and tumor aggressiveness in many tissues. In this study, our goal was to
determine the potential role of Id proteins, particularly Id1, during human SGC cell progression.
Methods: We first determined the expression levels of Id1 and Id2 in four SGC cell lines: two adenocarcinoma of
the salivary gland (HSG and HSY) and two adenoid cystic carcinoma (ACC2 and ACCM) cell lines. We then used
constructs that expressed antisense cDNAs to Id1 or Id2 to knockdown the expression of these proteins in cell lines
where they were highly expressed, and determined the effects of the knockdown on cell proliferation, migration
and invasion.
Results: Id1 mRNA and protein were detectable in all cell lines, and expression of Id2 was variable, from absent to
high. The ACC2 and ACCM cell lines expressed both Id1 and Id2, but Id1 was expressed at a higher level in the
more aggressive ACCM cell line in comparison toACC2 cells as confirmed by Id1 promoter-reporter assays. We
therefore focused on the ACCM cells for the remainder of the study. We found that proliferation and invasiveness
of ACCM cells were strongly reduced after Id1 knockdown whereas Id2 suppression had only a slight effect. Results
of scratch and colony formation assays also confirmed that ACCM cell aggressiveness was significantly reduced
upon Id1 knockdown. Finally, this knockdown resulted in reduced c-myc and enhanced cyclin-dependent kinase
inhibitor p21 expression.
Conclusions: These results demonstrate that Id1 plays an important role in the control of human SGC
cell aggressiveness and suggest a potential role as a marker of diagnosis, prognosis and progression of
SGCs. Id1 suppression could represent a novel and effective approach for the treatment of salivary
gland cancer.
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The development of aggressive cancers is a multistep
process involving many genetic and epigenetic alterations.
Identifying these alterations is essential to understanding
the mechanisms of cancer progression, and will enable the
development of more effective methods for diagnosis and
treatment. Human salivary gland cancer (SGC) is a typically* Correspondence: tomoki@m.ehime-u.ac.jp
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reproduction in any medium, provided the orslow-growing neoplasm of the secretory glands, most com-
mon in the minor and major salivary gland [1,2]. However,
SGCs also include highly aggressive tumors that invade the
adjacent tissues and metastasize to distant organs at an
early stage [1,3]. Some of the most common malignant
SGCs correspond to adenoid cystic carcinomas (ACC) and
the survival rates for this type of cancer at 10 and 20 years
are extremely poor [3-5]. Recurrent cases of ACC are par-
ticularly difficult to manage because of the ineffectiveness
of radio- and chemotherapy as well as the cosmetic and
anatomic limitations in performing wide surgical resectionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gently needed.
Recently, high expression levels of inhibitor of differ-
entiation (Id) genes have been observed in cell lines de-
rived from a variety of tumors and tumor tissues,
suggesting that Id proteins have been implicated in can-
cers originating from many organs [8]. Id proteins are a
class of helix-loop-helix (HLH) transcriptional regula-
tors. Constitutive expression of these proteins inhibits
the differentiation of various cell types through their
interaction with basic helix-loop-helix (bHLH) proteins
[9,10]. bHLH transcription factors are key regulators of
lineage- and tissue-specific gene expression in a number
of mammalian and non-mammalian organisms. bHLH
proteins act as obligate dimers binding DNA through com-
posite basic domains to regulate the transcription of target
genes containing E-boxes (CANNTG) in their promoters.
Id proteins dimerize with bHLH proteins, but because Id
proteins lack basic domains, Id-bHLH heterodimers fail to
bind DNA. Therefore, Id proteins are dominant negative
regulators of bHLH function [9,11].
To date, four members of the Id gene family have been
described (Id1-Id4) [12,13]. They are located on different
chromosomes and have different expression patterns
and functions. We hypothesized that Id proteins may be
involved in the regulation of SGC cell proliferation and
invasiveness. As a first step, we chose to focus our inves-
tigations on Id1 and Id2. Id4, however, also has a strong
association with some types of tumors [14,15] and Id3
displays similar expression pattern as Id1 [16]. We found
that both Id1 and Id2 were highly expressed in ACC2
and particularly ACCM cells, an aggressive sub-clone of
ACC2. However, only Id1 knockdown but not Id2 knock-
down triggered a significant reduction in the proliferative
and invasive phenotype of SGC cells, suggesting an impor-
tant role of Id1 in the regulation of SGC cell aggressiveness.
Methods
Cell culture
Four cell lines, all derived from human SGCs, were used
for the studies. HSG cells were established from an
adenocarcinoma of the submandibular gland [17], HSY
cells were also established from an adenocarcinoma [18],
ACC2 cells were established from an adenoid cystic car-
cinoma, and ACCM cells were a subpopulation of ACC2
with a highly aggressive phenotype [19]. The HSG and
HSY cell lines were a generous gift from Prof. Sato
(Tokushima University, Tokushima, Japan). The ACC2
and ACCM cell lines were purchased from the Cell Bank
of Type Culture Collection of the Chinese Academy of
Science (CBTCCCAS, Shanghai, China). All cell lines
were cultured in RPMI 1640 (University of California,
San Francisco, CA) supplemented with 10% FBS and
5 μg/ml insulin (Sigma) at 37°C in the presence of 5%CO2. For the serum-free conditions, FBS was omitted
from the medium.
Western blot analysis
Cells were lysed in 2X Laemmli buffer [20] and stored
at −70°C. The protein concentration was determined
using the DC protein assay kit (Bio-Rad). Samples (20–
30 μg of total protein) were separated by SDS-PAGE and
transferred to PVDF membranes (Hybond P; Amersham)
using standard methods [20]. Membranes were blocked
for 1 h at room temperature with TBST (20 mM Tris,
137 mM NaCl, 3.8 mM HCl, and 0.1% Tween-20) con-
taining 5% nonfat milk, and blots were probed with anti-
Id1, anti-Id2, anti-Id3, anti-p21, and anti-c-myc (Santa
Cruz Biotechnology), or anti-actin (Chemicon) antibodies
for 1 h. Membranes were washed and incubated with a
secondary antibody (either goat anti-rabbit or anti-mouse
IgG-horseradish peroxidase; Santa Cruz Biotechnology),
washed again, and developed for enhanced chemilumines-
cence using the Amersham ECL-Plus kit according to the
supplier’s instructions.
RNA extraction and northern blot analysis
RNA was isolated and purified as described by Chom-
czynski and Sacchi [21], and 15 μg of total RNA was
separated by electrophoresis using formaldehyde-agarose
gels, and transferred to a nylon membrane (Hybond N;
Amersham). The membrane was hybridized using either
a 32P-labeled human Id1 [22] or Id2 [23] cDNA probe,
washed, and exposed to a XAR-5 film for autoradiog-
raphy, as described previously [24]. Ribosomal 28S and
18S RNA were used as loading controls and to deter-
mine RNA integrity.
Id1 promoter-reporter assays
We used a 2.2-kb fragment corresponding to the 5-
upstream region of the human Id1 gene driving a lucifer-
ase gene (Id1-sbsluc) in the PGL-3 vector (Promega) as
previously described [25]. Cells were plated in 6-well
dishes at a density of 3x105 cells per well in RPMI 1640
medium supplemented with 10% FBS and 5 μg/ml insu-
lin. After 24 h, cells were co-transfected with 6 μg of
luciferase reporter plasmids and 2 μg of pCMVβ (Clontech)
using SuperFect transfection reagent (Qiagen). Vector
pCMVβ, containing bacterial β-galactosidase driven by the
constitutive CMV promoter, served as a control for vari-
ation in transfection efficiency. Three hours after transfec-
tion, cells were rinsed twice with serum-free medium,
cultured in RPMI 1640 medium with 10% FBS and 5 μg/ml
insulin for 48 h, scraped into 1 ml of PBS and collected by
centrifugation (13,000 rpm for 10 min). Cell pellets were
re-suspended in 80 μl of reporter lysis buffer (Promega)
and incubated for 10 min at room temperature. After cen-
trifugation, supernatants were collected and used for
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Assay System (Promega), β-Galactosidase Assay Kit (Clon-
tech), and a 2010 luminometer (Pharmingen). Luciferase
activities were normalized to β-galactosidase activities.
The pBabe-Id1 retroviral vector and virus production
The full-length human Id1 cDNA was excised from CMV-
Id1 and cloned into pBabe-puro [25], a gift from Dr.
Hartmut Land (ICRF, London, UK). Clones in which the
Id1 cDNA was inserted in the antisense orientation
(pBabe-Id1AS) were selected for use. The full-length hu-
man Id2 cDNA, a gift from Dr. Eiji Hara (Manchester,
UK), was also cloned into a pBabe vector in the antisense
orientation (pBabe-Id2AS). Either pBabe-Id1AS or pBabe-
Id2AS was transfected into the TSA54 packaging cell line
(Cell Genesis) using calcium phosphate [26]. Twenty-four
hours after transfection, the culture medium (containing
infectious virus) was harvested twice at 24 h intervals and
frozen at −80°C. Viral titers were determined using an
assay to detect reverse-transcriptase activity.
Retroviral infection
Approximately 8 RT units of pBabe-ctl (empty plasmid),
pBabe-Id1AS or pBabe-Id2AS was mixed with 5 ml of a
medium containing 4 μg/ml polybrene and added to
cells in 100-mm dishes. Cells expressing the retroviral
genes were selected using puromycin. The antibiotic
resulted in the death of all mock-infected cells within
3 days, and the surviving cells infected with pBabe-ctl,
pBabe-Id1AS, or pBabe-Id2AS were harvested.
[3H]Thymidine incorporation assay
Cells were cultured on coverslips in 1% serum, [3H]thy-
midine (μCi/ml; 60–80 Ci/mmol; Amersham) was in-
cluded during the final 16 h of culture, and cells were
fixed with a 1:1 methanol and acetone (vol/vol) solution.
Cell nuclei were stained with DAPI, diluted 1:10,000 in
PBS. [3H]Thymidine-labeling was developed as previously
described [27]. The percentage of labeled nuclei was cal-
culated by comparing the number of [3H]thymidine-
labeled nuclei with the number of DAPI-stained nuclei in
a given field using light and fluorescence microscopy.
Boyden chamber invasion assay
Invasion assays were performed in modified Boyden
chambers using 8 μm pore filter inserts in 24-well plates
(Collaborative Research). The filters were coated with
10–12 μl of ice-cold Matrigel (Collaborative Research).
Cells (approximately 80,000/well) were added to the
upper chamber in 200 μl of the appropriate medium
containing 0.1% BSA, and the lower chamber was filled
with 300 μl of NIH-3T3 cell-conditioned medium. Assays
were performed in triplicate or quadruplicate, and the re-
sults were averaged. After incubating for 20 h, cells werefixed with 2.5% glutaraldehyde in PBS and stained with
0.5% toluidine blue in 2% Na2CO3. The cells remaining in
Matrigel or those attached to the upper side of the filter
were removed with cotton tips. Cells on the lower side of
the filter were counted under light microscopy.
Cell migration assay
Cells were seeded in 6-well plates at a density of 1.0 × 105
cells per well. The following day, a scratch wound was
generated by scratching the bottom of the wells with a
pipette tip. Wells were rinsed with media to remove the
detached cells, and replaced with media containing 10%
serum. Cultures were then maintained for 24 h. Photo-
graphic images of each well were taken immediately fol-
lowing wound generation and again after 24 h. NIH Image
(National Institutes of Health, Bethesda, MD) was used
to measure the areas not covered by the migrating cells
at each time point. The experiments were performed
in triplicate.
Colony formation assay
Infected ACCM cells were trypsinized, re-suspended as
single cells, and plated in 6-well plates (coated with 0.5%
soft agar) at a density of approximately 100 cells per well
diluted in the upper layer of 0.33% soft agar. After 2
weeks, colonies were fixed with methanol and stained
with crystal violet. Colony numbers were counted under
the microscope. The number of colonies observed in anti-
sense groups were normalized and presented as a percent-
age of the average number of colonies in control groups.
Statistical analyses
Differences between groups were determined using a Stu-
dent’s t-test. P values <0.05 were considered statistically sig-
nificant. All statistical tests were performed using Statcel2
software (Statcel2, OMS, Tokyo).
Results
Id1 and Id2 gene expression in SGC cells
We first used Western blot analysis to compare the ex-
pression of Id1 and Id2 among four different SGC cell
lines, and to determine which cell line would be the
most suitable for knockdown experiments. Whereas all
cell lines displayed high levels of Id1 protein expression,
Id2 expression was more variable (Figure 1). Western
blot analysis demonstrated that ACCM cells, an aggres-
sive sub-clone of ACC2 cells, had the strongest expres-
sion of Id1 (and of Id3 as shown in Additional file 1:
Figure S1), whereas Id2 was expressed at similar levels
in ACC2 and ACCM cells, and almost undetectable in
HSG and HSY cells (Figure 1). Therefore, subsequent
analysis and experiments were performed using ACC2
and ACCM cells.
Figure 1 Id1 and Id2 protein expression in human SGC cell
lines. HSG, HSY, ACC2 and ACCM cells were analyzed for
expression of Id1 and Id2 by Western blotting. A loading control
was carried out by stripping the blot and re-probing with an
anti-actin antibody.
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ting demonstrated that Id1 mRNA expression was in-
deed much higher in ACCM cells than in ACC2 cells in
agreement with the analysis of Id1 protein expression
(Figure 2A). We also tested whether Id1 and Id2 expres-
sion was dependent upon the concentration of serum in
the media. We found that serum starvation did not have
any significant effect on the expression of Id1 and Id2
mRNA (Figure 2A) or protein (Figure 2B) (and of Id3Figure 2 Id1 and Id2 mRNA and protein expression in SGC cells in the
and ACCM cells cultured in 10% FBS or in serum-free medium (0%) were a
for RNA quantity and integrity, the ethidium bromide-stained gel is shown
Id2 protein expression in cells cultured under the same conditions as in (A
indicated by the expression of luciferase (a reporter driven by a human Id1
lines (p < 0.05, Student’s t test).protein as shown in Additional file 2: Figure S2). Next, we
performed Id1 promoter-reporter assays in ACC2 and
ACCM cells. These assays confirmed that higher levels of
Id1 expression were present in the most aggressive ACCM
cells compared to less aggressive ACC2 cells (approxi-
mately a three-fold difference in luciferase activity)
(Figure 2C).Effect of Id1 and Id2 knockdown on ACCM cell
proliferation and invasion
In order to investigate the potential role of Id1 and Id2
in the regulation of SGC cell aggressiveness, we used the
ACCM cells stably infected with the pBabe-Id1AS or
pBabe-Id2AS constructs. First, Id1 knockdown in the
ACCM pBabe-Id1AS cells was confirmed by Western
blotting (Figure 3A). Using [3H]thymidine-incorporation
assay, we then determined that Id1 knockdown resulted
in a significant reduction in cell proliferation relative to
the control group (Figure 3B). Similar to what was ob-
served for Id1 mRNA and protein expression, serum star-
vation did not have any significant effect on the reduced
proliferation rate produced by Id1 knockdown. Id1 knock-
down was also associated with modifications of the ex-
pression of proliferation markers. Whereas p21 expression
was strongly up-regulated, expression of the c-myc onco-
gene was down-regulated in ACCM pBabe-Id1AS cells
(Figure 3A). Finally, Id1 knockdown in SGC cells alsopresence or absence of serum. (A) Total RNA isolated from ACC2
nalyzed for expression of Id1 and Id2 by Northern blotting. To control
in the lower panel. (B) Western blot comparing the levels of Id1 and
) is shown. (C) Relative expression of Id1 in ACC2 and ACCM cells is
promoter). * indicates a significant difference between the two cell
Figure 3 Effects of Id1 knockdown on proliferation and invasiveness of ACCM cells. (A) Western blot shows the effects of Id1 knockdown
(Id1AS) on the expression of the cell proliferation markers c-myc and p21. (B) Effect of Id1 knockdown on the proliferation of ACCM cells was
determined in 10% serum or serum-free medium (0%) after 48 h. (C) Effect of Id1 knockdown on cell invasiveness was determined using Boyden
chamber invasion assays. Data represent the average of 6 independent experiments and are presented as percentage of controls (ctl). * indicates
significant differences between cell populations (p < 0.05, Student’s t test).
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the Boyden chamber invasion assay, we found that the
number of invading cells was reduced by approximately
50% in the antisense group when compared to control
(Figure 3C).
In contrast to Id1, successful knockdown of Id2 in
ACCM cells (Figure 4A) did not lead to a significant de-
crease in the proliferation rate or invasion of the cancer
cells (Figure 4B and C). In addition, only a minor reduc-
tion in c-myc and increase in p21 expression was ob-
served compared to control cells (Figure 4A).Id1 but not Id2 regulates cell migration and ability of
ACCM cells to form colonies
We used scratch and colony formation assays to exam-
ine the effects of Id1 and Id2 knockdown on additional
aspects of ACCM cell aggressiveness. Id1 knockdowntriggered a significant reduction in ACCM cell migration
in the scratch assay after 24 h when compared to control
cells (Figure 5A; p < 0.05, Student’s t test) as well as a
significant decrease in the number of colonies when we
used the colony formation assay (Figure 5B; p < 0.05, Stu-
dent’s t test). In contrast, Id2 knockdown did not affect
cell migration, since almost the entire area of the scratch
was filled after 24 h (Figure 6A), and failed to produce a
significant decrease in colony formation (Figure 6B).
Overall these data are in agreement with our results
obtained from the proliferation and invasion assays impli-
cating Id1 as a key factor in SGC cells.Discussion
The pathways controlling the proliferation and invasion
of aggressive and metastatic ACC are still not well un-
derstood, a gap in the field further hindered by the fact
Figure 4 Effects of Id2 knockdown on proliferation and invasiveness of ACCM cells. (A) Western blot shows the effects of Id2 knockdown
(Id2AS) on the expression of the cell proliferation markers c-myc and p21. (B) Effect of Id2 knockdown on the proliferation of ACCM cells was
determined in 10% serum or serum-free medium (0%) after 48 h. (C) Effect of Id2 knockdown on cell invasiveness was determined using Boyden
chamber invasion assays. Data represent the average of 6 independent experiments and are presented as percentage of controls (ctl). * indicates
significant differences between cell populations (p < 0.05, Student’s t test).
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ficult to obtain. Here, we compared four different SGC
cell lines, including the ACCM cell line, a highly meta-
static and aggressive variant obtained from the parental
ACC2 cells [19]. We found that Id1 mRNA and protein
expression was indeed higher in ACCM cells than in
ACC2 cells, whereas Id2 protein expression was almost
identical in both cell lines. These data suggested that a
constitutively high expression of Id1 (independent of the
presence of serum) was at least partly responsible for the
highly aggressive nature of ACCM cells. Since Id3 was
also expressed in these cells and may play a role in the
proliferative and/or invasive phenotype of SGCs, it is
possible that a double Id1/Id3 knockdown would further
increase the reduction of tumor cell aggressiveness.
Overall, the high levels of Id expression detected in
ACCM cells suggest that this family of proteins could be
responsible for the proliferative, migratory and invasive na-
ture of these cells, and suggest that these transcriptionalregulators could serve as diagnostic and/or prognostic fac-
tors of SGC. High expression levels of Id genes have been
observed in cell lines derived from a wide variety of tumors
and tumor tissues [28]. Id proteins, especially Id1, are asso-
ciated with a more aggressive and invasive behavior, as well
as with a less differentiated tumor phenotype, and in some
kinds of tumors, as markers of cancer diagnosis and pro-
gression [28]. Our results demonstrating a different role of
Id1 and Id2 in ACCM cells suggest that SGCs differ from
other types of cancer in which Id1 and Id2 appear to play a
more equivalent role. For example, Id1 and Id2 are both
over-expressed in pancreatic cancer cells [29], and are both
considered prognostic markers of squamous cell carcinoma
metastasis in the esophageal region [30].
Upon Id1 knockdown, c-myc expression was repressed
and p21 protein was strongly up-regulated. On the other
hand, there was a lack of modulation of c-myc and p21
expression after Id2 knockdown. Therefore, we can specu-
late that Id1 protein is, at least indirectly, associated with
Figure 5 Effects of Id1 knockdown on ACCM cell migration and
colony formation. (A) Images show scratch wounds using pipette
tips and compare ACCM-control cells (Ctl) and ACCM-Id1-antisense
cells (Id1AS) immediately (0 hr) or 24 hr after scratches were inflected.
(B) Results of colony formation assays comparing ACCM-control cells
(Ctl) and ACCM-Id1-antisense cells (Id1AS) are shown. Bars represent the
percentage of number of colonies in Id1AS cells relative to control cells.
* indicates a significant difference between cell populations (Student’s
t test, p < 0.05).
Figure 6 Effects of Id2 knockdown on ACCM cell migration and colon
compare ACCM-control cells (Ctl) and ACCM-Id2-antisense cells (Id2AS) imm
colony formation assays comparing ACCM-control cells (Ctl) and ACCM-Id2
number of colonies in Id2AS cells relative to control cells. * indicates a sign
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cancer cells, silencing Id1 induced the expression of the cell
cycle regulatory proteins p16 and p21 and triggered a
change in MMP-9 levels [31]. We previously reported that
in human aggressive SGC cells [32] and in metastatic breast
cancer cells [33], introduction of the progesterone receptor
and treatment with progestin was sufficient to reduce Id1
expression, down-regulation of c-myc and MMP-9, up-
regulation of p21 and consequently a decrease in the ag-
gressive phenotype of the cells. The down-regulation of
proteins such as matrix metallo-proteinases could explain
the effects of Id1 knockdown on the reduction of SGC
cell invasion.
Moreover, the significant effects of Id1 knockdown,
but not of Id2 knockdown, on cell migration (measured
using the scratch assay) and on the ability of the cells to
grow in an anchorage-independency fashion (measured
using the soft agar assay) provide additional support for
the key role of Id1 during SGC cell progression.
Conclusions
The results of this study indicate that Id1 expression is
correlated with a highly aggressive phenotype of SGC
cells and may be associated with the malignant progres-
sion of salivary gland epithelial cells. Knockdown of Id1
decreased the rate of proliferation, growth in soft agar,
migration and invasion of ACCM cells, indicating that
suppression of Id1 may impact SGC progression in pa-
tients. We are now testing the role of Id1 on SGC cell
metastasis in vivo as the next logical step in understand-
ing the importance of Id1 during SGC progression. In
conclusion, we propose that suppression of Id1 gene ex-
pression may represent a novel and effective approach
for the treatment of SGC.y formation. (A) Images show scratch wounds using pipette tips and
ediately (0 hr) or 24 hr after scratches were inflected. (B) Results of
-antisense cells (Id2AS) are shown. Bars represent the percentage of
ificant difference between cell populations (Student’s t test, p < 0.05).
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Additional file 1: Figure S1. Id3 protein expression in human SGC cell
lines. HSG, HSY, ACC2 and ACCM cells were analyzed for expression of
Id3 by Western blotting. Loading control was carried out by stripping the
blot and re-probing with an anti-actin antibody.
Additional file 2: Figure S2. Id3 protein expression in SGC cells in the
presence or absence of serum. Western blot comparing the levels of Id3
protein expression in ACC2 and ACCM cells cultured in 10% FBS or in
serum-free medium (0%) is shown.
Abbreviations
ACC: Adenoid cystic carcinomas; bHLH: Basic helix-loop-helix; HLH:
Helix-Loop-Helix; Id: Inhibitor of differentiation; SGC: Salivary gland cancer.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TS designed the study and drafted the manuscript; RM and AOI performed
the experiments; SDM, HH and PYD supervised the experiments and edited
the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by grants from the Japanese Ministry of Education,
Culture, Sports, Science and Technology (to T.S.), and from the National
Institutes of Health (CA082548 to P.Y.D.; CA135281 to S.D.M. and P.Y.D.).
Author details
1Department of Oral and Maxillofacial Surgery, Ehime University School of
Medicine, 454 Shitsukawa, Toon-City, Ehime 791-0295, Japan. 2California Pacific
Medical Center, Cancer Research Institute, San Francisco, CA 94107, USA.
Received: 27 June 2012 Accepted: 18 March 2013
Published: 22 March 2013
References
1. Lima SS, Soares AF, de Amorim RF, Freitas RA: Epidemiologic profile of
salivary gland neoplasms: analysis of 245 cases. Rev Bras Otorrinolaringol
2005, 71:335–340.
2. Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y,
Hatakeyama D, Fujitsuka H, Yamashita T, Shibata T: Intraoral minor salivary
gland tumors: a clinicopathological study of 82 cases. Int J Oral Maxillofac
Surg 2005, 34:528–532.
3. Lopes MA, Santos GC, Kowalski LP: Multivariate survival analysis of 128 cases
of oral cavity minor salivary gland carcinomas. Head Neck 1998, 20:699–706.
4. Jones AS, Hamilton JW, Rowley H, Husband D, Helliwell TR: Adenoid cystic
carcinoma of the head and neck. Clin Otolaryngol Allied Sci 1997, 22:434–443.
5. Spiro RH: Distant metastasis in adenoid cystic carcinoma of salivary
origin. Am J Surgery 1997, 174:495–498.
6. Marandas P, Dharkar D, Davis A, Leridant AM, Pacheco Ojeda L, Micheau C,
Wibault P, Schwaab G: Malignant tumours of the parotid: a study of 76
patients. Clin Otolaryngol 1990, 15:103–109.
7. Takagi D, Fukuda S, Furuta Y, Yagi K, Homma A, Nagahashi T, Inuyama Y:
Clinical study of adenoid cystic carcinoma of the head and neck.
Auris Nasus Larynx 2001, 28:S99–102.
8. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM: Id proteins in cell growth
and tumorigenesis. Cancer Cell 2003, 3:525–530.
9. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: a
negative regulator of helix-loop-helix DNA binding proteins. Cell 1990,
61:49–59.
10. Norton JD, Deed RW, Craggs G, Sablitzky F: Id helix-loop-helix proteins in
cell growth and differentiation. Trends Cell Biol 1998, 8:58–65.
11. Norton JD: ID helix-loop-helix proteins in cell growth, differentiation and
tumorigenesis. J Cell Sci 2000, 113:3897–3905.
12. Riechmann V, van Crüchten I, Sablitzky F: The expression pattern of Id4, a
novel dominant negative helix-loop-helix protein, is distinct from Id1,
Id2 and Id3. Nucleic Acids Res 1994, 22:749–755.
13. Riechmann V, Sablitzky F: Mutually exclusive expression of two dominant-
negative helix-loop-helix (dnHLH) genes, ld4 and ld3, in the developingbrain of the mouse suggests distinct regulatory roles of these dnHLH
proteins during cellular proliferation and differentiation of the nervous
system. Cell Growth Differ 1995, 6:837–843.
14. Lee YS, Kang JW, Lee YH, Kim DW: ID4 mediates proliferation of astrocytes
after excitotoxic damage in the mouse hippocampus. Anat Cell Biol 2011,
44:128–134.
15. Kuzontkoski PM, Mulligan-Kehoe MJ, Harris BT, Israel MA: Inhibitor of DNA
binding-4 promotes angiogenesis and growth of glioblastoma
multiforme by elevating matrix GLA levels. Oncogene 2010, 29:3793–802.
16. Lowery JW, Frump AL, Anderson L, DiCarlo GE, Jones MT, de Caestecker MP:
ID family protein expression and regulation in hypoxic pulmonary
hypertension. Am J Physiol Regul Integr Comp Physiol 2010, 299:1463–1477.
17. Sato N, Kyakumoto S, Sawano K, Ota M: Proliferative signal transduction
by epidermal growth factor (EGF) in the human salivary gland
adenocarcinoma (HSG) cell line. Biochem Mol Biol Int 1996, 38:597–606.
18. Myoken Y, Myoken Y, Okamoto T, Kan M, McKeehan WL, Sato JD, Takada K:
Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF
receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence
of growth. Int J Cancer 1996, 65:650–657.
19. Guan XF, Qiu WL, He RG, Zhou XJ: Selection of adenoid cystic carcinoma
cell clone highly metastatic to the lung: an experimental study. Int J Oral
Maxillofac Surg 1997, 26:116–119.
20. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual.
Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem
1987, 162:156–159.
22. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-
related genes encoding helix-loop-helix proteins are required for G1
progression and are repressed in senescent human fibroblasts. J Biol
Chem 1994, 269:2139–2145.
23. Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J,
Desprez PY: Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix
proteins that regulate mammary epithelial cell proliferation,
differentiation, and apoptosis. J Biol Chem 2001, 276:39213–39219.
24. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J,
Desprez PY: A role for Id-1 in the aggressive phenotype and steroid hormone
response of human breast cancer cells. Cancer Res 2000, 60:1332–1340.
25. Morgenstern JP, Land H: Advanced mammalian gene transfer: high titre
retroviral vectors with multiple drug selection markers and a complementary
helperfree packaging cell line. Nucleic Acids Res 1990, 18:3587–3596.
26. Gorman C: High efficiency gene transfer into mammalian cell. In DNA
Cloning. Edited by Glover DM. Oxford, United Kingdom: IRL; 1986:143–211.
27. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J: A
novel pathway for mammary epithelial cell invasion induced by the
helix-loop-helix protein Id-1. Mol Cell Biol 1998, 18:4577–4588.
28. Israel MA, Hernandez MC, Florio M, Andres-Barquin PJ, Mantani A, Carter JH,
Julin CM: Id gene expression as a key mediator of tumor cell biology.
Cancer Res 1999, 59:1726–1730.
29. Maruyama H, Kleeff J, Wildi S, Friess H, Büchler MW, Israel MA, Korc M: Id-1
and Id-2 are overexpressed in pancreatic cancer and in dysplastic
lesions in chronic pancreatitis. Am J Pathol 1999, 155:815–822.
30. Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC,
Wang X, Chan KW: Id-1 and Id-2 are markers for metastasis and prognosis
in oesophageal squamous cell carcinoma. Br J Cancer 2007, 97:1409–1415.
31. Asirvatham AJ, Carey JP, Chaudhary J: ID1-, ID2-, and ID3-regulated gene
expression in E2A positive or negative prostate cancer cells. Prostate
2007, 67:1411–1420.
32. Yoshimura T, Sumida T, Liu S, Onishi A, Shintani S, Desprez PY, Hamakawa
H: Growth inhibition of human salivary gland tumor cells by introduction
of progesterone (Pg) receptor and Pg treatment. Endocr Relat Cancer
2007, 14:1107–1116.
33. Sumida T, Itahana Y, Hamakawa H, Desprez PY: Reduction of human
metastatic breast cancer cell aggressiveness on introduction of either
form A or B of the progesterone receptor and then treatment with
progestins. Cancer Res 2004, 64:7886–7892.
doi:10.1186/1471-2407-13-141
Cite this article as: Sumida et al.: Targeting Id1 reduces proliferation and
invasion in aggressive human salivary gland cancer cells. BMC Cancer
2013 13:141.
